Загрузка видео...

Не удалось загрузить видео

На главную

Biology has been “guess and check” for too long The missing piece? Predictive models! Patrick Hsu, co-founder of @ArcInstitute, is using AI to transform drug discovery

gradypb's profile picture

Pat Grady

19,302 subscribers

45,942 просмотров • 1 год назад •via X (Twitter)

Здоровье и велнесНовости и политикаНаука и технологии
LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 6

Фото профиля Pat Grady
Pat Grady1 год назад

More here: YouTube: Apple: Spotify:

Фото профиля ksminnovation
ksminnovation1 год назад

AI is transforming healthcare! A KSM-led study shows AI can detect Celiac disease 4 years earlier @TalPatalon @MedPredict

Фото профиля Josh Pacini
Josh Pacini1 год назад

@pdhsu @arcinstitute Predict models are 100% the future of drug development, excited to listen to the rest of the podcast!

Фото профиля EquiTea
EquiTea1 год назад

@pdhsu @arcinstitute love the insights

Фото профиля Boardy Boardman
Boardy Boardman1 год назад

@sequoia @pdhsu @arcinstitute Predictive models in bio are game-changing. The intersection with AI could accelerate discovery timelines from decades to years. Exciting to see @ArcInstitute pushing this forward.

Фото профиля Bioengineering Bro
Bioengineering Bro1 год назад

@pdhsu @arcinstitute Are his models based on cell data? If so, I'm pretty skeptical as cell data is so noisy I would trust test tube or even animal level data more at scale

Похожие видео

Our understanding of the human body is fragmented and disconnected. At @ArcInstitute co-founder Patrick Hsu and team are working to change that, building systems that integrate multimodal health information—from genetics to glucose levels—to transform how we understand our bodies.
1:28

Our understanding of the human body is fragmented and disconnected. At @ArcInstitute co-founder Patrick Hsu and team are working to change that, building systems that integrate multimodal health information—from genetics to glucose levels—to transform how we understand our bodies.

Josephine Chen

25,084 просмотров • 1 год назад

The next frontier of biology is AI-powered. Watch @Illumina CEO Jacob Thaysen explain how combining AI with genomics and proteomics will transform drug discovery, along with disease diagnosis and prevention.
0:38

The next frontier of biology is AI-powered. Watch @Illumina CEO Jacob Thaysen explain how combining AI with genomics and proteomics will transform drug discovery, along with disease diagnosis and prevention.

AMD

11,903 просмотров • 6 месяцев назад

"The future is really bright in AI and drug discovery." Sean McClain, Founder and CEO of Absci, shared the CES stage with healthcare leaders to illustrate how the compute partnership with AMD has scaled their ability to screen over a million drugs in one single day, resulting in better models for drug discovery.
1:14

"The future is really bright in AI and drug discovery." Sean McClain, Founder and CEO of Absci, shared the CES stage with healthcare leaders to illustrate how the compute partnership with AMD has scaled their ability to screen over a million drugs in one single day, resulting in better models for drug discovery.

AMD

15,346 просмотров • 6 месяцев назад

During #DrugDiscoveryDay Ryan Cross the Science Boss had an in-depth discussion with Arena BioWorks co-founder Stuart Schreiber around small molecule drug discovery, AI in chemical biology, & new models of funding science. Watch this conversation & more On Demand:
1:44

During #DrugDiscoveryDay Ryan Cross the Science Boss had an in-depth discussion with Arena BioWorks co-founder Stuart Schreiber around small molecule drug discovery, AI in chemical biology, & new models of funding science. Watch this conversation & more On Demand:

Endpoints News

30,992 просмотров • 2 лет назад

“Some of these research problems we’ve been going after really are holy grail predictive problems for drug design - and we’ve made some incredible breakthroughs there, which have really stunned our chemists.” On Sequoia Capital’s Training Data podcast, our Chief AI Officer Max Jaderberg talks about the scale of AI drug discovery and its potential to transform how we design new medicines. Listen to the full podcast at the link below:
0:29

“Some of these research problems we’ve been going after really are holy grail predictive problems for drug design - and we’ve made some incredible breakthroughs there, which have really stunned our chemists.” On Sequoia Capital’s Training Data podcast, our Chief AI Officer Max Jaderberg talks about the scale of AI drug discovery and its potential to transform how we design new medicines. Listen to the full podcast at the link below:

Isomorphic Labs

12,294 просмотров • 1 год назад

For years, the AI race has been about building bigger models. Sudip Roy, Co-Founder of adaption, believes the next frontier is AI that continuously adapts instead. If he's right, one of AI's biggest assumptions is about to change. Listen to the latest episode of Nebius for Startups podcast: 🎧
0:31

For years, the AI race has been about building bigger models. Sudip Roy, Co-Founder of adaption, believes the next frontier is AI that continuously adapts instead. If he's right, one of AI's biggest assumptions is about to change. Listen to the latest episode of Nebius for Startups podcast: 🎧

Nebius

10,818 просмотров • 28 дней назад

New Unsupervised Learning with Joshua Meier @ NeurIPS (Chai Discovery) on how AI x drug discovery is starting to inflect and: - The 3 waves of AI biotech - How AI models think differently than chemists - Building "Photoshop for molecules" - Deciding what to open source
0:38

New Unsupervised Learning with Joshua Meier @ NeurIPS (Chai Discovery) on how AI x drug discovery is starting to inflect and: - The 3 waves of AI biotech - How AI models think differently than chemists - Building "Photoshop for molecules" - Deciding what to open source

Jacob Effron

12,351 просмотров • 1 год назад

ReaSyn is helping to revolutionize drug discovery 🔬 Our new generative AI predicts synthetic pathways for molecules using step-by-step reasoning accelerating drug discovery and scientific breakthroughs. Read more and try the code ➡️ #NVIDIAResearch
0:38

ReaSyn is helping to revolutionize drug discovery 🔬 Our new generative AI predicts synthetic pathways for molecules using step-by-step reasoning accelerating drug discovery and scientific breakthroughs. Read more and try the code ➡️ #NVIDIAResearch

NVIDIA AI Developer

25,451 просмотров • 10 месяцев назад

Can AI cure disease & make science faster? Patrick Hsu Jorge Conde and Erik Torenberg discuss (00:45) The Moonshot: Virtual Cells and Human Biology (02:58) Interdisciplinary Collaboration at Arc Institute (05:11) The Role of AI in Biology (10:18) Understanding Virtual Cells (22:13) Biotech and Pharma Industry Insights (28:13) Capital Intensity and Technological Advancements (30:12) Market Impact and Industry Trends (33:19) Future Technological Breakthroughs (38:15) AI in Drug Discovery (45:50) Investment Focus and Future Prospects
55:38

Can AI cure disease & make science faster? Patrick Hsu Jorge Conde and Erik Torenberg discuss (00:45) The Moonshot: Virtual Cells and Human Biology (02:58) Interdisciplinary Collaboration at Arc Institute (05:11) The Role of AI in Biology (10:18) Understanding Virtual Cells (22:13) Biotech and Pharma Industry Insights (28:13) Capital Intensity and Technological Advancements (30:12) Market Impact and Industry Trends (33:19) Future Technological Breakthroughs (38:15) AI in Drug Discovery (45:50) Investment Focus and Future Prospects

a16z

53,540 просмотров • 11 месяцев назад

AMD CTO Mark Papermaster sits down with Sean McClain, Founder and CEO of Absci, to discuss the future of drug discovery, and how AI is revolutionizing this process. Hear how AI is accelerating innovation, cutting costs, and paving the way for personalized medication. Tune in now:
0:46

AMD CTO Mark Papermaster sits down with Sean McClain, Founder and CEO of Absci, to discuss the future of drug discovery, and how AI is revolutionizing this process. Hear how AI is accelerating innovation, cutting costs, and paving the way for personalized medication. Tune in now:

AMD

14,834 просмотров • 1 год назад

"AMD is helping Absci really push that frontier of AI drug discovery." - @Abscibio Founder and CEO, Sean McClain shares a deeper dive into our collaboration to impact healthcare through AI.
1:06

"AMD is helping Absci really push that frontier of AI drug discovery." - @Abscibio Founder and CEO, Sean McClain shares a deeper dive into our collaboration to impact healthcare through AI.

AMD

17,104 просмотров • 6 месяцев назад

AI is catalyzing scientific discovery into health and disease. To accelerate progress, we’re building one of the world’s largest computing systems dedicated to non-profit life science research that we’ll leverage to create predictive models of whole cells
1:08

AI is catalyzing scientific discovery into health and disease. To accelerate progress, we’re building one of the world’s largest computing systems dedicated to non-profit life science research that we’ll leverage to create predictive models of whole cells

Chan Zuckerberg Initiative

111,460 просмотров • 2 лет назад

The ambition at Isomorphic Labs is immense – they’re rethinking drug discovery from the ground up, using AI. 💊 Join Head of Medicinal Drug Design rebecca paul & Chief AI Officer Max Jaderberg as they share the possibilities of AI in tackling disease with host Hannah Fry. Watch their conversation ↓ Timecodes: 00:00 Intro 02:11 AI & Disease 05:30 AI in Biology 06:51 Molecules and Proteins 12:05 AlphaFold 3 14:40 Demo 16:20 Human-AI collaboration 24:30 Drug Design Challenges 39:00 Beyond Animal Models 44:35 AI Drug Future 46:30 Outro
47:07

The ambition at Isomorphic Labs is immense – they’re rethinking drug discovery from the ground up, using AI. 💊 Join Head of Medicinal Drug Design rebecca paul & Chief AI Officer Max Jaderberg as they share the possibilities of AI in tackling disease with host Hannah Fry. Watch their conversation ↓ Timecodes: 00:00 Intro 02:11 AI & Disease 05:30 AI in Biology 06:51 Molecules and Proteins 12:05 AlphaFold 3 14:40 Demo 16:20 Human-AI collaboration 24:30 Drug Design Challenges 39:00 Beyond Animal Models 44:35 AI Drug Future 46:30 Outro

Google DeepMind

78,030 просмотров • 1 год назад

What could scaling unlock for biology? Introducing ProGen3- our next AI foundation models for protein generation. We develop compute-optimal scaling laws up to 46B parameters on 1.5T tokens with real evidence in the wet lab. +we solve a new set of challenges for drug discovery
2:36

What could scaling unlock for biology? Introducing ProGen3- our next AI foundation models for protein generation. We develop compute-optimal scaling laws up to 46B parameters on 1.5T tokens with real evidence in the wet lab. +we solve a new set of challenges for drug discovery

Ali Madani

80,665 просмотров • 1 год назад

🤝 Alphabet and NVIDIA are expanding their decade-long partnership to advance agentic AI, robotics, drug discovery, and more. This involves deep co-engineering with integrated platforms, open-source frameworks, and managed services. ✅ Google Cloud is one of the first to bring the NVIDIA Blackwell platform to the cloud. ✅ Google Distributed Cloud using NVIDIA Confidential Computing on #NVIDIABlackwell for enterprises to run Google Gemini on-premises. ✅ Integration of the NVIDIA AI platform across Vertex AI, Cluster Director and Google Kubernetes Engine. ✅ Bringing the NVIDIA Nemotron family of open models to Vertex AI Model Garden. Watch the full video to learn more ➡️
0:30

🤝 Alphabet and NVIDIA are expanding their decade-long partnership to advance agentic AI, robotics, drug discovery, and more. This involves deep co-engineering with integrated platforms, open-source frameworks, and managed services. ✅ Google Cloud is one of the first to bring the NVIDIA Blackwell platform to the cloud. ✅ Google Distributed Cloud using NVIDIA Confidential Computing on #NVIDIABlackwell for enterprises to run Google Gemini on-premises. ✅ Integration of the NVIDIA AI platform across Vertex AI, Cluster Director and Google Kubernetes Engine. ✅ Bringing the NVIDIA Nemotron family of open models to Vertex AI Model Garden. Watch the full video to learn more ➡️

NVIDIA AI Infrastructure

268,567 просмотров • 7 месяцев назад

2026: the year of explosive AI innovation. Fireworks AI Co-founder & CEO Lin Qiao speaks on how the massive expansion of customized inference and models is creating speed of light production to scale timelines.
0:20

2026: the year of explosive AI innovation. Fireworks AI Co-founder & CEO Lin Qiao speaks on how the massive expansion of customized inference and models is creating speed of light production to scale timelines.

NVIDIA

35,963 просмотров • 3 месяцев назад

Full podcast with Ala Shaabana (shτbshτb), co-founder of Bittensor, and Shardul Bansal, co-founder & CEO of Oro, is LIVE. Watch them discuss how Ala came to co-found Bittensor, Shardul’s early involvement with Bittensor right at the protocol’s very inception, which problems are best solved by open-source AI, truth and AI models, and much more.
53:50

Full podcast with Ala Shaabana (shτbshτb), co-founder of Bittensor, and Shardul Bansal, co-founder & CEO of Oro, is LIVE. Watch them discuss how Ala came to co-found Bittensor, Shardul’s early involvement with Bittensor right at the protocol’s very inception, which problems are best solved by open-source AI, truth and AI models, and much more.

ORO

97,106 просмотров • 3 месяцев назад

Walk the #BIO2026 show floor with Kimberly Powell, NVIDIA VP of Healthcare, as she shares what’s exciting about the latest BioNeMo toolkit announcement. BioNeMo is helping bring AI-driven biology and drug discovery closer to the next experiment, with tools for researchers and developers to build, customize and deploy AI applications across the life sciences ecosystem.
1:37

Walk the #BIO2026 show floor with Kimberly Powell, NVIDIA VP of Healthcare, as she shares what’s exciting about the latest BioNeMo toolkit announcement. BioNeMo is helping bring AI-driven biology and drug discovery closer to the next experiment, with tools for researchers and developers to build, customize and deploy AI applications across the life sciences ecosystem.

NVIDIA

45,520 просмотров • 1 месяц назад

The cast of “Tron: Ares” try to guess how many episodes of “American Horror Story” their co-star Evan Peters has appeared in to date. Fact check: The correct answer is 87 episodes. He has been credited for a total of 100.
0:36

The cast of “Tron: Ares” try to guess how many episodes of “American Horror Story” their co-star Evan Peters has appeared in to date. Fact check: The correct answer is 87 episodes. He has been credited for a total of 100.

The AHS Zone

13,937 просмотров • 10 месяцев назад